University of California, Los Angeles
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1919-05-23
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucla.edu
Randomized Crossover Study of Magnesium Supplementation
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2Inflammation
- Interventions
- Other: Placebo
- First Posted Date
- 2008-08-20
- Last Posted Date
- 2012-06-19
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 14
- Registration Number
- NCT00737815
- Locations
- 🇺🇸
UCLA General Clinical Research Center, Los Angeles, California, United States
An Assessment of the Safety of Varenicline in Methamphetamine-dependent Volunteers
Phase 1
Completed
- Conditions
- Methamphetamine AddictionAmphetamine AddictionCrystal Meth Addiction
- Interventions
- Drug: Varenicline, then placebo
- First Posted Date
- 2008-07-11
- Last Posted Date
- 2018-03-13
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 8
- Registration Number
- NCT00713479
- Locations
- 🇺🇸
UCLA NPI, Los Angeles, California, United States
Modafinil Effects on Cognition in Schizophrenia Patients
- First Posted Date
- 2008-07-08
- Last Posted Date
- 2017-09-29
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 29
- Registration Number
- NCT00711464
- Locations
- 🇺🇸
University of California, Davis School of Medicine, Sacramento, California, United States
🇺🇸University of California, Los Angeles, Los Angeles, California, United States
Role of Intraoperative Thymoglobulin in Decreasing Ischemia-Reperfusion Injury in Pediatric Heart Transplant Recipients
Not Applicable
Withdrawn
- Conditions
- Ischemia Reperfusion InjuryHeart Transplantation
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2013-06-18
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT00709293
- Locations
- 🇺🇸
Mattel Children's Hospital at UCLA, Los Angeles, California, United States
Nesiritide - Dilated Cardiomyopathy
Not Applicable
Completed
- Conditions
- Dilated Cardiomyopathy
- Interventions
- Drug: 5% Dextrose
- First Posted Date
- 2008-07-03
- Last Posted Date
- 2008-07-03
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 20
- Registration Number
- NCT00709163
- Locations
- 🇺🇸
Mattel Children's Hospital at UCLA, Los Angeles, California, United States
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- First Posted Date
- 2008-06-11
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 800
- Registration Number
- NCT00695214
- Locations
- 🇺🇸
UCLA Santa Monica Medical Center, Santa Monica, California, United States
Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)
Phase 1
Completed
- Conditions
- Suicide
- Interventions
- Behavioral: SAFETYBehavioral: Enhanced usual care
- First Posted Date
- 2008-06-06
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 72
- Registration Number
- NCT00692302
- Locations
- 🇺🇸
University of California, Los Angeles, California, United States
Randomized, Double-Blind Cross-Over Trial Of Buprenorphine and Low-Dose Naloxone Versus Buprenorphine
Not Applicable
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2008-05-16
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 12
- Registration Number
- NCT00679458
- Locations
- 🇺🇸
UCLA Integrated Substance Abuse Programs Outpatient Research Center, Los Angeles, California, United States
Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
Phase 3
Completed
- Conditions
- Obsessive-Compulsive DisorderGeneralized Anxiety Disorder
- Interventions
- First Posted Date
- 2008-05-07
- Last Posted Date
- 2019-05-10
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 17
- Registration Number
- NCT00674219
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease
Completed
- Conditions
- Huntington's Disease
- First Posted Date
- 2008-05-02
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 42
- Registration Number
- NCT00670709
- Locations
- 🇺🇸
UCLA Laboratory of Brain, Behavior,a nd PHarmacology, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath